KFDA approves 10 Baraclude generics
Published: 2012-10-26 06:57:00
Updated: 2012-10-26 06:57:00
Ten Korean pharmaceutical firms, including CJ Pharm, SK Chemicals and Hanmi Pharm, are allowed to produce generic versions of the hepatitis B drug Baraclude, the Korea Food and Drug Administration officials said Thursday.
The health watchdog is also expected to give the go ahead for more local...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
